CORC

浏览/检索结果: 共251条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Measurement of very-high-energy diffuse gamma-ray emission from Galactic plane with LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Zhang, Rui;  Zhao, Shiping;  Zhang, Yi;  Yuan, Qiang;  Cao, Zhen
收藏  |  浏览/下载:17/0  |  提交时间:2023/01/23
Design and expected performances of the large acceptance calorimeter for the HERD space mission 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Pacini, Lorenzo;  Adriani, Oscar;  Bai, Yong-Lin;  Bao, Tian-Wei;  Berti, Eugenio
收藏  |  浏览/下载:35/0  |  提交时间:2022/12/30
Class forge: Boosting feature encoder for few-shot learning with synthesized classes 会议论文
Shenzhen, China, July 5-9, 2021
作者:  Rui-Qi Wang;  Xu-Yao Zhang;  Cheng-Lin Liu
收藏  |  浏览/下载:3/0  |  提交时间:2022/04/07
GSS: Graph-based subspace learning with shots initialization for few-shot recognition 会议论文
Shenzhen, China, July 5-9, 2021
作者:  Rui-Qi Wang;  Xu-Yao Zhang;  Cheng-Lin Liu
收藏  |  浏览/下载:4/0  |  提交时间:2022/04/07
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:46/0  |  提交时间:2019/12/05
Halogenation of 1,1-diarylethylenes by N-halosuccinimides 会议论文
作者:  Zhang, Ge;  Bai, Rui-Xue;  Li, Chu-Han;  Feng, Chen-Guo;  Lin, Guo-Qiang
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Copper-catalyzed asymmetric silylative cyclization of cyclohexadienone-containing 1,6-enynes 会议论文
作者:  Lin, Guo-Qiang;  Tian, Ping;  He, Cheng-Yu;  Xie, Li -Bo;  Ding, Rui
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
Popularity Prediction Caching Using Hidden Markov Model for Vehicular Content Centric Networks 会议论文
2019 20TH INTERNATIONAL CONFERENCE ON MOBILE DATA MANAGEMENT (MDM 2019), 2019-01-01
作者:  Yao, Lin;  Wang, Yuqi;  Xia, QiuFen;  Xu, Rui
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:37/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:39/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace